The “value of a human life” and Supply Chain Choices

A New York Times article (February 20, 2011) describes estimates of the value of a human life across US government agencies – $ 9.1 million by the EPA, $ 7.9 million by the FDA, $ 6 million by DOT, and a number between 1 and 10 million recommended by the OMB. The impact of these estimates is the justification for specific labels on drugs by the FDA, the need for warning labels on cigarette packages with cancer victim pictures by the FDA, stronger roofs on cars by the DOT etc.  These examples suggest that design choices and associated risk is calculated by using estimates of their value – and thus may be significant. But should this choice of the value of human life be allowed to vary across US government agencies and thus have different effects across industries ? Should it also be allowed to vary across time (moving up or down) and across decisions ? How should private industry supply chains incorporate these estimates into the choices across companies ?

Advertisements

About aviyer2010

Professor
This entry was posted in Operations Management, Supply Chain Issues and tagged , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s